Fortive jumps after an earnings beat and a higher profit outlook
Earnings results
- EPS beat +8.5%
Actual: $0.77 · Cons.: $0.71 (adjusted diluted EPS from continuing operations)
- Revenue beat +3.5%
Actual: $1.1075B · Cons.: $1.07B (GAAP revenue from continuing operations)
- Guidance
Raised FY2026 adjusted diluted EPS to $3.10–$3.14 from $2.95–$3.05.
Earnings and the stock move
Fortive reported third-quarter results on October 28 and lifted its full-year adjusted profit outlook. Higher sales volumes supported the earnings beat, while the increased forecast suggests management expects strength to continue. Our analysis: the next test is whether operating-solutions momentum and better healthcare profitability can sustain earnings growth without relying as heavily on buybacks.
Q3 2026 earnings recap
Fortive rose 7.80% to $66.42 during trading on October 28, 2026 after beating earnings estimates and raising its profit outlook. Stronger demand gives investors more reason to expect growth beyond cost cuts.
- Fortive sells testing instruments, safety and facility software, and healthcare products. Revenue rose 7.8% to $1.11 billion, with 4.9% growth in sales volume.
- Adjusted EPS, or profit per share excluding specified costs, was $0.77 versus a $0.71 estimate: an 8.5% beat. Reported GAAP profit per share was $0.57.
- The full-year adjusted profit forecast rose to $3.1–$3.14 per share from $2.95–$3.05. That lifts the midpoint by 4%, giving the earnings beat more lasting significance.
- The strength was uneven: operating solutions revenue grew 9.8%, while healthcare grew 3.7%. Healthcare operating margin fell to 11.2% from 12.9%, leaving room for improvement.
- Free cash flow, cash left after capital spending, reached $283.8 million. Fortive also repurchased about $300 million of shares; fewer shares helped amplify profit-per-share growth.
- The rally clears July highs near $63.1–$64.6. Holding that area on a pullback would strengthen the breakout; the late-October range near $60–$61.7 is a lower area to watch.
Watch whether demand and healthcare profitability support the higher outlook. A weaker economy, cost pressure or a failed breakout could reverse part of the gain.
Financials and technicals
Charts through Oct 27, 2026. The session move above may reflect later news.
Technical setup and risks
The October 28 move clears July highs at $63.1–$64.6. A successful retest supports the breakout; closing below $63.1 weakens it. The $60–$61.7 late-October range is a lower support area. These are conditional price areas.
AI-assisted research with source and calculation checks. Prices may be delayed. Technical charts use the stated completed session, which can precede the quoted intraday move. Educational information; investing involves risk.